Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE OF FINANCIAL INSTRUMENTS

v3.21.2
FAIR VALUE OF FINANCIAL INSTRUMENTS
9 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
FAIR VALUE OF FINANCIAL INSTRUMENTS
NOTE 7: FAIR VALUE OF FINANCIAL INSTRUMENTS
The Company measures and records in its consolidated financial statements certain assets and liabilities at fair value. ASC Topic 820 “Fair Value Measurement and Disclosures,” establishes a fair value hierarchy for instruments measured at fair value that distinguishes between assumptions based on market data (observable inputs) and the Company’s own assumptions (unobservable inputs). This hierarchy consists of the following three levels:
Level 1 – Assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market.
Level 2 – Assets and liabilities whose values are based on inputs other than those included in Level 1, including quoted market prices in markets that are not active; quoted prices of assets or liabilities with similar attributes in active markets; or valuation models whose inputs are observable or unobservable but corroborated by market data.
Level 3 – Assets and liabilities whose values are based on valuation models or pricing techniques that utilize unobservable inputs that are significant to the overall fair value measurement.
Certain assets are measured at fair value on a nonrecurring basis; that is, the instruments are not measured at fair value on an ongoing basis but are subject to fair value adjustments in certain circumstances (for example, when there is evidence of impairment).
Current Assets and Other Financial Assets and Liabilities—Cash and cash equivalents, trade accounts receivable and trade accounts payable are measured at carrying value, which approximates fair value because of the short-term maturities of these instruments.
Contingent Consideration Payable—The Company measures the contingent consideration payable at fair value. The fair value of the contingent consideration utilized Level 3 inputs as it is based on significant inputs not observable in the market as of September 30, 2021, such as projected financial information and discount rate.
Debt—The Company measures its term loan and revolving facilities at original carrying value including accrued interest, net of unamortized deferred financing costs and fees. The fair value of the credit facilities approximates carrying value, as they consist of variable rate loans.
Warrant Liabilities—The Company classifies its Private Warrants as liabilities in accordance with ASC Topic 815. The Company estimates the fair value of the Private Warrants using a Black-Scholes options pricing model. The fair value of the Private Warrants utilized Level 3 inputs as it is based on significant inputs not observable in the market as of September 30, 2021.
The fair value of the Private Warrants was estimated at September 30, 2021 using a Black-Scholes options pricing model and the following assumptions:
Input September 30, 2021
Asset price $ 11.55
Exercise price $ 11.50
Risk-free interest rate 0.70%
Expected volatility 42.0%
Expected term (years) 3.74
Dividend yield 0.0%
The fair value of warrant liabilities as of September 30, 2021 was $2.5 million. The changes in the warrant liabilities during the nine months ended September 30, 2021 were as follows (in thousands):
Reclassification of fair value of Private Warrants to warrant liabilities as of January 1, 2021 $ 8,139 
Cumulative impact of change in fair value of Private Warrants in 2020 (1,161)
Transfer of Private Warrants to Public Warrants (2,502)
Change in fair value of warrant liabilities in Q1 2021 3,523 
Fair value of warrant liabilities as of March 31, 2021 $ 7,999 
Change in fair value of warrant liabilities in Q2 2021 241 
Fair value of warrant liabilities as of June 30, 2021 $ 8,240 
Transfer of Private Warrants to Public Warrants (3,555)
Change in fair value of warrant liabilities in Q3 2021 (2,178)
Fair value of warrant liabilities as of September 30, 2021 $ 2,507